DENTSPLY SIRONA (XRAY) Expected to Announce Quarterly Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) is expected to release its earnings data before the market opens on Thursday, February 27th. Analysts expect DENTSPLY SIRONA to post earnings of $0.47 per share and revenue of $920.26 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $18.98 on Thursday. The company has a 50-day moving average of $18.96 and a 200-day moving average of $21.77. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of -9.17, a PEG ratio of 1.74 and a beta of 0.96. DENTSPLY SIRONA has a 52 week low of $17.21 and a 52 week high of $34.91. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.37%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s payout ratio is -30.92%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on XRAY. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Tuesday. UBS Group reduced their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their target price for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Needham & Company LLC reiterated a “buy” rating and set a $25.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, February 11th. Ten analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $25.85.

View Our Latest Research Report on DENTSPLY SIRONA

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.